Edition:
India

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

7,352.25INR
24 Sep 2018
Change (% chg)

Rs-354.65 (-4.60%)
Prev Close
Rs7,706.90
Open
Rs7,640.00
Day's High
Rs7,706.65
Day's Low
Rs7,180.00
Volume
14,862
Avg. Vol
22,310
52-wk High
Rs7,850.00
52-wk Low
Rs4,851.00

Latest Key Developments (Source: Significant Developments)

GSK To Review Of Horlicks, Consumer Nutrition Products To Fund Novartis Deal
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Glaxosmithkline Plc ::GLAXOSMITHKLINE - TRANSACTION WITH NOVARTIS EXPECTED TO BE ACCRETIVE TO ADJUSTED EARNINGS IN 2018 AND THEREAFTER, AND TO STRENGTHEN CASH FLOW GENERATION.GSK ALSO TO INITIATE STRATEGIC REVIEW OF HORLICKS AND OTHER CONSUMER NUTRITION PRODUCTS TO SUPPORT TRANSACTION FUNDING..‍REVIEW WILL INCLUDE AN ASSESSMENT OF GROUP'S SHAREHOLDING IN INDIAN SUBSIDIARY, GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD​.STRATEGIC REVIEW WILL INCLUDE AN ASSESSMENT OF GSK'S 72.5% SHAREHOLDING IN COMPANY.‍EXPECTS OUTCOME OF STRATEGIC REVIEW TO BE CONCLUDED AROUND END OF 2018​.GLAXOSMITHKLINE - CONSUMER HEALTHCARE BUSINESS TO CONTINUE TO INVEST IN GROWTH OPPORTUNITIES FOR OTC, ORAL HEALTH BRANDS, SUCH AS SENSODYNE AND ENO.GLAXOSMITHKLINE - ACTIVELY INVESTING IN PHARMACEUTICAL, VACCINES BUSINESSES, INCLUDING BUILDING NEW MANUFACTURING CAPACITY IN VEMGAL, KARNATAKA, NASHIK.GLAXOSMITHKLINE - BUYOUT TO BE STRUCTURED AS CANCELLATION OF NOVARTIS' SHARES IN JV IN CONSIDERATION OF JOINT VENTURE PAYING BUYOUT PRICE TO NOVARTIS.GSK HAS ENTERED INTO A COMMITTED FACILITIES AGREEMENT TO SUPPORT FUNDING OF BUYOUT.AGREED TO PAY BREAK FEE OF $200 MILLION IN NOVARTIS DEAL.JOINT VENTURE WILL CONTINUE TO PAY DIVIDENDS TO GSK AND NOVARTIS IN ACCORDANCE WITH ITS ESTABLISHED PRACTICE UNTIL COMPLETION.  Full Article

India's Glaxosmithkline Consumer Healthcare Sept qtr profit up about 4 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd :Sept quarter net profit 1.92 billion rupees versus profit of 1.84 billion rupees last year.Sept quarter revenue from operations 11.15 billion rupees versus 11.93 billion rupees last year.  Full Article

Glaxosmithkline Consumer Healthcare Dec-qtr profit down about 8 pct
Monday, 13 Feb 2017 

Glaxosmithkline Consumer Healthcare Ltd : Dec quarter net profit 1.36 billion rupees . Dec quarter net sales 9.22 billion rupees . Net profit in dec quarter last year was 1.49 billion rupees as per Ind-AS; net sales was 10.56 billion rupees .Says tenure of Subidh Bharagava as non executive chairman been extended.  Full Article

BRIEF-India's Glaxosmithkline Consumer Healthcare March-Qtr Profit Rises

* MARCH QUARTER PROFIT 2.12 BILLION RUPEES VERSUS PROFIT OF 1.76 BILLION RUPEES LAST YEAR